YAP1 and cancer: Increased activity of YAP1, in conjunction with its binding partner TEAD, was previously shown to promote proliferation and metastasis in multiple cancers, including HNSCC (Lamar et al. 2012; Chia et al. 2017; Omori et al. 2020).